2208. Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis

Authors

John M. McLaughlin, Pfizer, Collegeville
Farid L. Khan, Pfizer, Collegeville
Elizabeth Begier, Pfizer Vaccines, Dublin
David Swerdlow, Pfizer, Collegeville
Luis Jodar, Pfizer Vaccines, Dublin
Ann R. Falsey, Rochester Regional HealthFollow

Department

Infectious Diseases

Document Type

Conference Proceeding

Publication Title

Open Forum Infectious Diseases

Conference Name

IDWeek

Conference Date

2022-10-19 - 2022-10-23

First Page

ofac492.1827

DOI

10.1093/ofid/ofac492.1827

Volume

9

Issue

Supplement_2

Publication Date

12-1-2022

Comments

Session: 240. Respiratory Infections - Viral

Recommended Citation

McLaughlin, J. M., Khan, F. L., Begier, E., Swerdlow, D., Jodar, L., & Falsey, A. R. (2022). 2208. Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases, 9 (Supplement_2), ofac492.1827. https://doi.org/10.1093/ofid/ofac492.1827